(BOSTON) – The Wyss Institute at Harvard University, along with Milad Alucozai, MSc, MPH, DrPH, is excited to announce the launch of the “Code to Cure” newsletter. Co-hosted by Alucozai and the Wyss Institute, this series will explore the convergence of artificial intelligence (AI), biology, and healthcare, highlighting the technologies and innovations shaping the future of human and planetary health.
About the Newsletter
“Code to Cure” will bring together a diverse community of scientific minds, startup founders, industry leaders, and subject matter experts to delve into the transformative potential of computational biology. The newsletter will explore the tools and practices that are empowering companies to develop personalized treatments, accelerate drug discovery, enhance diagnostics, and improve healthcare delivery. The inaugural article will be published in early October, with subsequent issues released every two months.
Meet the Host
Milad Alucozai is a neuroscientist, entrepreneur, biotech executive, and global investor with extensive experience at the intersection of biology, healthcare, and deep tech. He is a pioneer in bioengineering and computational advancements, integrating machine learning and AI into the realms of biology and medicine. Committed to commercializing transformative technologies and fostering startup ecosystems, Alucozai is a thought leader and mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute.
“We are living in a new era for biology, where research is driven by the convergence of powerful technologies along with new concepts and methods,” said Alucozai. “One of the highlights of my professional career has been being a Visiting Scholar and Mentor at the Wyss Institute. Building a community around these advancements will be key to powering future innovations. There is no better group that aligns with the values and interests around this intersection, and I am excited for this next chapter.”
About the Wyss Institute
The Wyss Institute is a research and development engine for disruptive innovation powered by Biologically Inspired Engineering with visionary people at its heart. Its mission is to transform healthcare and the environment by developing groundbreaking technologies that emulate the way Nature builds and accelerate their translation into commercial products through formation of startups and corporate partnerships to bring about positive near-term impact in the world.
“We are excited to be partnering with Milad on this venture,” said Angelika Fretzen, Ph.D., M.B.A., COO and Technology Translation Director at the Wyss Institute. “He has been an invaluable resource to our ecosystem, generously investing his time to mentor our scientists and scale several of our companies. Through ‘Code to Cure,’ we aim to build a comprehensive playbook for those building or considering building scientific advancements in the computational biology and health sectors. By sharing diverse perspectives from scientists, startup CEOs, industry leaders, and other key stakeholders, we hope to equip the next generation of founders with the knowledge and insights they need to navigate this dynamic landscape.”
Join the Conversation
Each entry will be posted on the Wyss’ website and as part of a LinkedIn Newsletter series. On LinkedIn, readers can subscribe to “Code to Cure” to receive notifications as each article comes out. Readers are encouraged to actively participate in the community by asking questions, making suggestions, and sharing their own thoughts and experiences.
Subscribe to “Code to Cure” today and embark on a journey of discovery at the intersection of AI, biology, and healthcare. Together, let’s explore the groundbreaking technologies that are shaping the future of human and planetary health.